175 related articles for article (PubMed ID: 24659911)
1. Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence.
Carmignani L; Bianchi R; Cozzi G; Grasso A; Macchione N; Marenghi C; Melegari S; Rosso M; Tondelli E; Maggioni A
Rev Urol; 2013; 15(4):145-53. PubMed ID: 24659911
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
3. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
[TBL] [Abstract][Full Text] [Related]
4. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE
Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456
[TBL] [Abstract][Full Text] [Related]
5. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
Audenet F; Traxer O; Bensalah K; Rouprêt M
World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
[TBL] [Abstract][Full Text] [Related]
6. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).
Audenet F; Yates DR; Cussenot O; Rouprêt M
Urol Oncol; 2013 May; 31(4):407-13. PubMed ID: 20884249
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ.
Tomisaki I; Kubo T; Minato A; Fujimoto N
Cancer Invest; 2018 Feb; 36(2):152-157. PubMed ID: 29393701
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role?
Rastinehad AR; Smith AD
J Endourol; 2009 Apr; 23(4):563-8. PubMed ID: 19335155
[TBL] [Abstract][Full Text] [Related]
9. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.
Cosentino M; Palou J; Gaya JM; Breda A; Rodriguez-Faba O; Villavicencio-Mavrich H
World J Urol; 2013 Feb; 31(1):141-5. PubMed ID: 22552732
[TBL] [Abstract][Full Text] [Related]
10. [Primary upper urinary tract tumors and subsequent location in the bladder].
Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544
[TBL] [Abstract][Full Text] [Related]
11. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
Horiguchi H; Yoneyama T; Hatakeyama S; Tokui N; Sato T; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Narita S; Kawaguchi T; Ohyama C
Med Oncol; 2018 Feb; 35(4):41. PubMed ID: 29480348
[TBL] [Abstract][Full Text] [Related]
12. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
13. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
14. The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test.
Hsieh TF; Chen CC; Chang CH; Yu AL; Ma WL; Shyr CR
Exp Toxicol Pathol; 2013 Jul; 65(5):703-8. PubMed ID: 23069010
[TBL] [Abstract][Full Text] [Related]
15. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Tan WS; Panchal A; Buckley L; Devall AJ; Loubière LS; Pope AM; Feneley MR; Cresswell J; Issa R; Mostafid H; Madaan S; Bhatt R; McGrath J; Sangar V; Griffiths TRL; Page T; Hodgson D; Datta SN; Billingham LJ; Kelly JD
Eur Urol; 2019 Jan; 75(1):63-71. PubMed ID: 30274699
[TBL] [Abstract][Full Text] [Related]
17. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
[TBL] [Abstract][Full Text] [Related]
18. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
[TBL] [Abstract][Full Text] [Related]
19. [Long-term outcome of initial treatment with Bacillus Calmette-Guérin for carcinoma in situ of the upper urinary tract].
Kita Y; Soda T; Mizuno K; Matsuoka T; Nakanishi S; Asai S; Taoka R; Inoue K; Terai A
Hinyokika Kiyo; 2011 Jul; 57(7):353-7. PubMed ID: 21832868
[TBL] [Abstract][Full Text] [Related]
20. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure.
Okubo K; Ichioka K; Terada N; Matsuta Y; Yoshimura K; Arai Y
BJU Int; 2001 Sep; 88(4):343-7. PubMed ID: 11564018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
